SunHydrogen's photoelectrochemical and integrated PV-electrolysis modules reached solar-to-hydrogen efficiency above 10% in testing at Sparc Hydrogen's laboratories and produced more hydrogen under concentrated sunlight; under a new Technology Collaboration and Intellectual Property Protection Agreement, the companies will advance the modules through laboratory and pilot-scale testing at Sparc Hydrogen's SHARP facility in South Australia, followed by a jointly funded techno-economic assessment of hydrogen cost.

Proven leader to drive sharper execution and faster breakthroughs across research, diagnostics, and advanced therapeutics

A long-simmering plan to develop an aerospace cluster at the Eastern Iowa Airport is nearly ready to come to a full boil.

Perspective Therapeutics, Inc. has announced that the first meningioma patient was dosed with [212Pb]VMT-α-NET in the Company’s ongoing Phase 1/2a study.

IDT announces a collaboration with Illumina to enable integrated oncology research workflows that combine IDT library preparation with DRAGEN™ secondary analysis, streamlining the path from sequencing to insight for somatic oncology research applications.

SunHydrogen has successfully installed hydrogen modules built with its latest design improvements at its pilot demonstration system at the University of Texas at Austin's Hydrogen ProtoHub.

Perspective Therapeutics, Inc. has announced that the first patients were dosed with [212Pb]VMT-α-NET and [212Pb]PSV359 in two new cohorts of Phase 1/2a studies in neuroendocrine tumors and solid tumors, respectively.